| 1 | [SID24819677] | Active | AbsAC35_uM | 0.388 | Counterscreen for inhibitors of NLG for Luciferase Activators Measured in Cell-Based System Using Plate Reader - 2146-03_Inhibitor_Dose_CherryPick_Activity [AID624404, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | AbsAC35_uM | 0.388 [uM] | | BioAssay | Counterscreen for inhibitors of NLG for Luciferase Activators Measured in Cell-Based System Using Plate Reader - 2146-03_Inhibitor_Dose_CherryPick_Activity | | AID | 624404 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID24819677] | Active | AbsAC26_uM | 5.71 | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_Dose_CherryPick_Activity [AID624491, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | AbsAC26_uM | 5.71 [uM] | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624491 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID24819677] | Active | CC50 | 12.48 | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) [AID2410, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | CC50 | 12.48 [uM] | | BioAssay | An HTS Cytotoxicity Screen to evaluate New Inhibitors of Respiratory Syncytial Virus (RSV) | | AID | 2410 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID24819677] | Active | CC50 | 22.09 | Vero 76 Cytoxicity Assay for VEEV Compounds [AID588719, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | CC50 | 22.09 [uM] | | BioAssay | Vero 76 Cytoxicity Assay for VEEV Compounds | | AID | 588719 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID24819677] | Active | CC50 | 43.53 | A Cell Based Secondary Assay To Explore Cytotoxicity of West Nile Virus Anti-Viral Hit Compounds [AID1650, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | CC50 | 43.53 [uM] | | BioAssay | A Cell Based Secondary Assay To Explore Cytotoxicity of West Nile Virus Anti-Viral Hit Compounds | | AID | 1650 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID24819677] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 7 | [SID24819677] | Active | | | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588692, Type: screening] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588692 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID24819677] | Active | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID24819677] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors [AID1813, Type: screening] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors | | AID | 1813 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID24819677] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 11 | [SID24819677] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID504326, Type: screening] | OPRD1 gene product [Homo sapiens] [gi:63477962] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors | | AID | 504326 | | BioAssay type | screening | | Target | OPRD1 gene product [Homo sapiens] [gi:63477962] | | PubMed | | | Data Table |  |
|
| 12 | [SID24819677] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 13 | [SID24819677] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 14 | [SID24819677] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID652245, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 652245 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 15 | [SID24819677] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID652245, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 652245 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 16 | [SID24819677] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 17 | [SID24819677] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 18 | [SID24819677] | Active | | | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) [AID504692, Type: screening] | HTR5A gene product [Homo sapiens] [gi:13236497] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A) | | AID | 504692 | | BioAssay type | screening | | Target | HTR5A gene product [Homo sapiens] [gi:13236497] | | PubMed | | | Data Table |  |
|
| 19 | [SID24819677] | Active | | | uHTS Colorimetric assay for identification of inhibitors of Scp-1 [AID493091, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | uHTS Colorimetric assay for identification of inhibitors of Scp-1 | | AID | 493091 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 20 | [SID24819677] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 21 | [SID24819677] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 22 | [SID24819677] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 23 | [SID24819677] | Inactive | Potency | 3.5481 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | Potency | 3.5481 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID24819677] | Inactive | | | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602247, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602247 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID24819677] | Inactive | | | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line [AID602248, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line | | AID | 602248 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID24819677] | Inactive | | | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line [AID602250, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line | | AID | 602250 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID24819677] | Inactive | | | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells [AID602274, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells | | AID | 602274 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID24819677] | Inactive | | | HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity [AID602340, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity | | AID | 602340 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID24819677] | Inactive | | | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity [AID602342, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602342 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID24819677] | Inactive | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID24819677] | Inactive | | | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity [AID623901, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Small molecule inhibitors of miR122 Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity | | AID | 623901 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID24819677] | Inactive | Potency | | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen [AID624418, Type: confirmatory] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen | | AID | 624418 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID24819677] | Inactive | | | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease [AID624483, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease | | AID | 624483 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID24819677] | Inactive | | | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors [AID602141, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors | | AID | 602141 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID24819677] | Inactive | Potency | | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID24819677] | Inactive | Potency | | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID24819677] | Inactive | | | High Throughput Imaging Assay for Hepatic Lipid Droplet Formation [AID1656, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | High Throughput Imaging Assay for Hepatic Lipid Droplet Formation | | AID | 1656 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID24819677] | Inactive | | | MLPCN Platelet Activation -Dense Granule Release [AID1663, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | MLPCN Platelet Activation -Dense Granule Release | | AID | 1663 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID24819677] | Inactive | | | Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission [AID1775, Type: other] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission | | AID | 1775 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID24819677] | Inactive | | | uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line [AID2380, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line | | AID | 2380 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID24819677] | Inactive | IC50 | | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) [AID2391, Type: confirmatory] | |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV) | | AID | 2391 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 42 | [SID24819677] | Inactive | Potency | | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504850, Type: confirmatory] | |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Confirmation screen for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504850 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 43 | [SID24819677] | Inactive | | | Small Molecules that selectively kill Giardia lamblia: qHTS [AID540267, Type: screening] | |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Small Molecules that selectively kill Giardia lamblia: qHTS | | AID | 540267 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 44 | [SID24819677] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 45 | [SID24819677] | Inactive | | | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity [AID588334, Type: screening] | |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity | | AID | 588334 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 46 | [SID24819677] | Inactive | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID24819677] | Inactive | | | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies [AID588358, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies | | AID | 588358 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID24819677] | Inactive | | | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity [AID588436, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity | | AID | 588436 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID24819677] | Inactive | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID24819677] | Inactive | | | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID588674, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24819677 | | CID | 45105759 | | Outcome | Inactive | | BioAssay | Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 588674 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|